Site reference ID 232 — Vestavia Hills, Alabama

Site reference ID 232 is a clinical research site located in Vestavia Hills, Alabama, United States 35216.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site reference ID 232 has participated in 1 clinical trials.

Therapeutic areas: Uterine Fibroids, Heavy Menstrual Bleeding.

Sponsors: ObsEva SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Vestavia Hills

Browse all research sites in Alabama · View every site in Vestavia Hills

• Novo Nordisk Investigational Site
• Research Site
• Novartis Investigative Site
• Achieve Clinical Research, LLC
• Young H. Choi Eye Surgery Center
• Accel Research Sites Network - Birmingham- Site Number : 8400003
• Accel Research Site Networks - Birmingham CRU / Elite
• Alabama Eye MD
• National Centers for Pain Management and Research
• Alabama Orthopaedic Center- Research
• Surgical Dermatology Group

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site reference ID 232?

Site reference ID 232 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site reference ID 232 conducted?

Site reference ID 232 has 1 clinical trials on record. Their work covers Uterine Fibroids, Heavy Menstrual Bleeding.

Is Site reference ID 232 accredited by Crixeo Clinical Trials?

Site reference ID 232 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site reference ID 232?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.